Going global: How US biopharma can unlock worldwide access
While non-US companies expand their presence in the States, US biopharma companies are struggling to expand patient access globally. Janice MacLennan, Founder & CEO of Nmblr, writes that a shift in strategy is needed. US biopharma innovation is thriving. The market generated around $220 billion in revenue… Read More
